Therapeutic Targeting of Cancer

Therapeutic targeting of cancer involves designing and applying treatments that specifically target cancer cells and the mechanisms driving their growth, survival, and spread, while minimizing harm to normal cells. This approach includes a range of strategies, from targeted therapies and immunotherapies to novel drug delivery systems and combination therapies. It involves a multifaceted approach that leverages advancements in molecular biology, immunology, and nanotechnology. Continued research and innovation are crucial for improving the efficacy, safety, and accessibility of cancer treatments, ultimately aiming to provide personalized and effective care for cancer patients.

  • Gene Therapy
  • Chemo-Immunotherapy
  • Hormonal Therapy
  • Chimeric antigen receptor (CAR) T-cell therapy
  • Monoclonal Antibodies

 

      Related Conference of Therapeutic Targeting of Cancer

      November 25-26, 2024

      7th International Conference on Anti-Cancer Drugs & Therapies

      Vancouver, Canada
      November 28-29, 2024

      14th World Congress on Breast Cancer

      Paris, France
      December 10-11, 2024

      8th Global Meeting on Oncology and Radiology

      Dubai, UAE
      December 11-12, 2024

      34th Experts Meet On Cancer Research & Therapy

      Paris, France
      December 12-13, 2024

      44th Euro Congress on Cancer Science & Therapy

      Rome, Italy
      March 10-11, 2025

      3rd World Congress on Oral Cancer

      Paris, France
      March 24-25, 2025

      10th World Conference on Breast and Cervical Cancer

      Paris, France
      March 24-25, 2025

      25th World Congress on Cancer and Diagnostics

      London, UK
      June 16-17, 2025

      26th World Congress on Cancer Summit

      Amsterdam, Netherlands

      Therapeutic Targeting of Cancer Conference Speakers

        Recommended Sessions

        Related Journals

        Are you interested in